Stock Research for SGEN


Featured Broker: Ally Invest

Get the due diligence for another stock.


SGEN Stock Chart & Research Data

The SGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


SGEN Due diligence Resources & Stock Charts

The SGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View SGEN Detailed Price Forecast - CNN Money CNN View SGEN Detailed Summary - Google Finance
Yahoo View SGEN Detailed Summary - Yahoo! Finance Zacks View SGEN Stock Research & Analysis -

Stock Analysis

TradeIdeas View SGEN Trends & Analysis - Trade-Ideas Barrons View SGEN Major Holders - Barrons
NASDAQ View SGEN Call Transcripts - NASDAQ Seeking View SGEN Breaking News & Analysis - Seeking Alpha
Spotlight View SGEN Annual Report - OTC Report View SGEN OTC Short Report -
TradeKing View SGEN Fundamentals - TradeKing Charts View SGEN SEC Filings - Bar Chart
WSJ View Historical Prices for SGEN - The WSJ Morningstar View Performance/Total Return for SGEN - Morningstar
MarketWatch View the Analyst Estimates for SGEN - MarketWatch CNBC View the Earnings History for SGEN - CNBC
StockMarketWatch View the SGEN Earnings - StockMarketWatch MacroAxis View SGEN Buy or Sell Recommendations - MacroAxis
Bullish View the SGEN Bullish Patterns - American Bulls Short Pains View SGEN Short Pain Metrics -

Social Media Mentions

StockTwits View SGEN Stock Mentions - StockTwits PennyStocks View SGEN Stock Mentions - PennyStockTweets
Twitter View SGEN Stock Mentions - Twitter Invest Hub View SGEN Investment Forum News - Investor Hub
Yahoo View SGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View SGEN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for SGEN - Insider Cow View Insider Transactions for SGEN - Insider Cow
CNBC View SGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for SGEN - OTC Markets
Yahoo View Insider Transactions for SGEN - Yahoo! Finance NASDAQ View Institutional Holdings for SGEN - NASDAQ

Stock Charts

FinViz View SGEN Stock Insight & Charts - StockCharts View SGEN Investment Charts -
BarChart View SGEN Stock Overview & Charts - BarChart Trading View View SGEN User Generated Charts - Trading View

Latest Financial News for SGEN

Seattle Genetics (SGEN) Down 6.1% Since Last Earnings Report: Can It Rebound?
Posted on Saturday March 09, 2019

Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ImmunoGen Failure Casts a Shadow on Antibody-Drug Conjugates
Posted on Wednesday March 06, 2019

Flagship ImmunoGen (IMGN) ovarian cancer drug candidate Mirvetuximab Soravtansine just failed to meet its primary endpoint in Phase III studies. The failed candidate is an antibody-drug conjugate (ADC), a drug model that uses an antibody as a homing device to lock on to cancer cells and deliver a targeted drug payload. The entire ADC approach to cancer treatment could arguably be called into question here.

Pullback Strategies: 10 Stocks That Could Fall the Fastest
Posted on Wednesday March 06, 2019

These stocks are heavily owned by high-turnover hedge funds, and thus are likely to face severe selling pressure once these funds turn bearish.

Seattle Genetics, Inc. (NASDAQ:SGEN): Are Analysts Optimistic?
Posted on Tuesday March 05, 2019

Seattle Genetics, Inc.'s (NASDAQ:SGEN): Seattle Genetics, Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. On 31 December 2018, theRead More...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.